The acute ischemic stroke therapeutics market refers to the market for drugs and treatments that are used to treat patients who have experienced a stroke caused by a blockage in a blood vessel supplying the brain with oxygen and nutrients. These therapies aim to restore blood flow to the affected area of the brain and minimize the damage caused by the stroke.
The global market for acute ischemic stroke therapeutics is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of stroke worldwide, the growing ageing population, and the development of new and effective therapies for stroke treatment.
The market for acute ischemic stroke therapeutics is also benefiting from government initiatives and collaborations aimed at promoting stroke awareness and improving the accessibility of stroke treatment in developing countries.
Obesity, Atherosclerosis, Hypertension, and Old Age: The High-Risk Factors Fueling Acute Ischemic Stroke Therapeutics Market Growth.
Cardiovascular diseases, such as myocardial infarction (MI) and stroke, are major public health concerns and the leading causes of disability and death worldwide. Among the different types of stroke, AIS is the most common, resulting from a blockage in the oxygen-rich blood supply to a specific part of the brain, either due to plaque or a blood clot. Timely treatment with alteplase is crucial as it can prevent the onset of disability or even death if administered within 3-4 hours of the first symptoms of a stroke. According to the Centers for Disease Control and Prevention (CDC), ischemic stroke accounts for about 87% of all strokes, making it the second-leading cause of death globally. This type of stroke occurs when a blood clot obstructs an artery that carries oxygen-rich blood to the brain. Another type of ischemic stroke is a transient ischemic attack (TIA), which lasts less than five minutes and also results from a blockage in blood flow to the brain.
Anticoagulant Reversal Agents Shortage May Pose a Threat to the Growth of the Acute Ischemic Stroke Therapeutics Market, Says New Study.
Anticoagulants are crucial in treating AIS, though there are potential side effects such as excessive bleeding. Fortunately, antidotes are available to reverse these side effects. Vitamin K, protamine, and prothrombin complex concentrates are commonly used to counteract the action of warfarin and heparin. However, the acceptability of newer anticoagulants, known as NOACs, is hindered by the limited availability of reversal agents in the market. Although idarucizumab has been approved by the US FDA as an antidote to dabigatran, direct thrombin inhibitors or Factor Xa inhibitors do not yet have specific reversal agents. As a result, the market growth of anticoagulants is negatively impacted due to the unmet need for reversal agents. Ongoing research is needed to address this issue and ensure the safe and effective use of anticoagulants.
The global acute ischemic stroke therapeutics market is to increase from US$ XX.X million in 2020 to US$ XX.X million by 2025. The market is estimated to grow with a compound annual growth rate (CAGR) of XX.X% (2020-2025). Some of the prominent players in the market are Bayer, Biogen, Boehringer Ingelheim, Daiichi Sankyo, Pfizer, Roche, Sanofi. The research report on the global acute ischemic stroke therapeutics market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.
The global economy is highly affected by the COVID-19. Various sectors in the economy are much affected by this pandemic. The global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the acute ischemic stroke therapeutics market. This report is helpful for business and industry practitioners. The study specifically intended to assist in explaining, directing, and understanding the potential of the acute ischemic stroke therapeutics markets. The study focuses on providing readers with an understanding of developments in the industry. The report also provides detailed insights on market segments, market forecasts, leading players, market drivers, and inhibitors.
Goals and objectives of the global acute ischemic stroke therapeutics market study
- Define and discuss the global market for acute ischemic stroke therapeutics.
- Analyze the various segments of the market as well as the market dynamics of acute ischemic stroke therapeutics.
- Categorize acute ischemic stroke therapeutics segments with escalating growth potential and value the segments' future market.
- Analyze the key trends related to different segments and countries that help in figuring the acute ischemic stroke therapeutics market.
- To check region-specific growth and development in the acute ischemic stroke therapeutics market.
- Analyze the historical and current value of each of these product segments in the end-user and geographic markets.
- Understand the foremost stakeholders of the market and the value of the competitive landscape of the leaders of the market.
- To study the plans, initiatives, and strategies for the development of the market.
The second chapter, market overview, provides an overview of the acute ischemic stroke therapeutics market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.
Global Acute Ischemic Stroke Therapeutics Market Segmentation
Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments, year-on-year growth projections that enable readers to identify potential market growth areas.
- Based on type, the global acute ischemic stroke therapeutics market is segmenting into thrombolytic therapeutics, antihypertensive therapeutics, antiplatelet therapeutics, anticoagulants.
- Based on application, the acute ischemic stroke therapeutics market is segmenting into hospitals, ambulatory surgical center, diagnostic centers.
Global Acute Ischemic Stroke Therapeutics Market Regional Analysis
Chapter 4, the regional analysis includes an in-depth analysis of the acute ischemic stroke therapeutics market by region. The chapter includes various regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each year's growth projections and a global share of value.
Global Acute Ischemic Stroke Therapeutics Market Competitive Analysis
Chapter 5, competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.
Global Acute Ischemic Stroke Therapeutics Market Company Profile
Chapter 6, the company profile of the report also covers key industry players working in the acute ischemic stroke therapeutics market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.
The study offers an exhaustive summary and estimate of the global market. It includes in-depth qualitative and quantitative analyses in the report that align with our customer's goals and objectives. Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients to invest in the market based on the current business situation, trends, and potential developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into the global market, its products, and market patterns.
